| 【Company Research】Hansoh Pharma (3692 HK) - Robust sales growth and sustainable BD momentum |
| 【Company Research】CR MixC Lifestyle (1209 HK) - Commercial biz to ride the trend, residential biz to upgrade quality |
| 【Company Research】Mindray (300760 CH) - Navigating near-term pressures; expect growth to resume in 2026E |
| 【公司研究】固生堂 (2273 HK) - 26年有望重回加速增长通道 |
| 【Sector Research】China Insurance - 1-2M26: Life sustained double-digit rise; P&C auto premiums dipped for two consecutive months |
| 【Company Research】SANY International (631 HK) - Multiple growth drivers ahead |
| 【Company Research】Meidong Auto (1268 HK) - Expect profit growth in FY26-27 following 2H25 new-car GPM recovery, new HIMA stores |
| CMBI Fixed Income - FUTLAN/FTLNHDs: An outperformer in a challenging operating environment |
| 【Company Research】3SBio (1530 HK) - Short-term pressure on product sales; ASCO 2026 in focus |
| 【Company Research】Yongda Automobiles (3669 HK) - Recover gradually |